The global cell separation market size was estimated at USD 9.64 billion in 2024 and is projected to reach USD 23.16 billion by 2033, growing at a CAGR of 10.55% from 2025 to 2033. Cell separation plays a vital role in a wide range of applications, including biologics design and development, therapeutic protein production, in vitro diagnostics, and other research-based studies.
The growing prevalence of chronic and infectious diseases, such as cancer and COVID-19, along with continuous government initiatives aimed at strengthening the biotechnology sector, are key factors driving market expansion. Additionally, product innovation remains a major contributor to market growth. Various companies, including NanoString Technologies, Levitas Bio, and Bionano Genomics, have focused on strategic product development and portfolio expansion to enhance their market presence. For instance, in April 2022, Levitas Bio introduced the LeviCell EOS System, a next-generation platform for cell separation. This advanced system enables precise selection of viable cells and offers higher throughput compared to the company’s previous models.
Moreover, the COVID-19 pandemic created new opportunities for researchers to explore the mechanisms of the virus and develop effective diagnostic and therapeutic solutions. In March 2020, the U.S. President signed an emergency spending bill allocating USD 3 billion toward research and development of vaccines, medical treatments, and diagnostic kits. This initiative significantly accelerated the demand for cell separation tools used in various research applications.
Cell separation or isolation techniques are essential in the development and production of biologics, including monoclonal antibodies and recombinant proteins, which have seen substantial growth over the past few decades. The rising focus on specialty drugs and personalized medicine has further propelled the demand for biologics. According to CAS, a division of the American Chemical Society, the biologics market is projected to reach USD 399.5 billion by 2025, underscoring the growing importance of cell separation technologies in the global life sciences industry.
Key Market Trends & Insights:
• The North America cell separation market accounted for the largest revenue share of 36.54% in 2024, making it the leading regional market globally. This dominance can be attributed to the presence of well-established biotechnology and pharmaceutical companies, advanced research infrastructure, and increased investments in life sciences research. Furthermore, a strong focus on the development of precision medicine and growing adoption of advanced cell-based therapies have further strengthened the region’s market position.
• Within North America, the U.S. cell separation industry is projected to experience substantial growth during the forecast period from 2025 to 2033. This growth is primarily driven by rising research activities in cell biology, regenerative medicine, and cancer research, coupled with government funding and collaborations between research institutions and private companies. Additionally, the increasing demand for biologics and advanced diagnostic tools is further fueling market expansion in the country.
• Based on product type, the consumables segment dominated the market with the highest share of 60.25% in 2024. This dominance is largely due to the frequent and repetitive use of consumables such as reagents, kits, and magnetic beads in research and clinical applications. The growing adoption of advanced cell separation techniques and increasing demand for high-quality consumables that ensure accuracy and reproducibility are key factors contributing to this segment’s strong performance.
• In terms of cell type, the animal cells segment captured the largest market share in 2024. The extensive use of animal cells in research activities, vaccine production, and biopharmaceutical manufacturing has played a crucial role in this segment’s growth. Moreover, continuous advancements in animal cell-based technologies and their applications in drug testing and toxicology studies have further supported market dominance.
• By end use, the hospitals and diagnostic laboratories segment held the highest market share in 2024. This can be attributed to the rising use of cell separation techniques in clinical diagnostics, disease detection, and treatment monitoring. The growing number of hospitals equipped with advanced laboratory facilities and the increasing prevalence of chronic and infectious diseases have further propelled the demand for cell separation technologies in this segment.
Order a free sample PDF of the Cell Separation Market Intelligence Study, published by Grand View Research.
Market Size & Forecast:
• 2024 Market Size: USD 9.64 Billion
• 2033 Projected Market Size: USD 23.16 Billion
• CAGR (2025-2033): 10.55%
• North America: Largest market in 2024
• Asia Pacific: Fastest growing market
Key Companies & Market Share Insights:
The global cell separation market is highly competitive, featuring a balanced mix of well-established technology leaders and rapidly emerging innovators. Each participant contributes to market expansion through a combination of extensive product portfolios, strategic global alliances, and continuous investments in automation and digital transformation. This dynamic environment fosters technological advancement and ensures a steady flow of innovative solutions catering to both research and clinical needs.
Thermo Fisher Scientific maintains a leading global position in the market, backed by its comprehensive portfolio that includes magnetic bead-based kits, Dynabeads, reagents, and advanced cell separation instruments. The company’s strong emphasis on research and development, along with its expansive distribution network, strengthens its global reach. Additionally, its ability to integrate cell separation technologies with downstream applications—such as cell analysis, cell culture, and molecular diagnostics—positions Thermo Fisher as a top-tier player across multiple segments of the industry.
Danaher Corporation, through its subsidiaries Cytiva and Beckman Coulter Life Sciences, also plays a pivotal role in the market. The company is recognized for its clinical-scale magnetic separation systems and automated platforms designed to seamlessly integrate with upstream bioprocessing workflows. Danaher’s influence continues to grow, particularly in GMP-compliant manufacturing and cell therapy applications, where precision, reliability, and scalability are critical to production success.
Meanwhile, innovative companies such as BD (Becton, Dickinson and Company), Terumo Corporation, and several other emerging players are increasingly gaining market traction. These companies focus on developing modular, compact, and customizable systems tailored to specific research and clinical applications. By emphasizing flexibility, sustainability, and cost-effectiveness, they are becoming preferred partners in rapidly evolving fields such as regenerative medicine, immunotherapy, and precision diagnostics. Their adaptability and customer-focused innovations contribute significantly to the overall growth and diversification of the global cell separation market.
Key Players
• Thermo Fisher Scientific, Inc.
• BD
• Danaher
• Terumo Corp.
• STEMCELL Technologies Inc.
• Bio-Rad Laboratories, Inc.
• Merck KGaA
• Agilent Technologies, Inc.
• Corning Inc.
• Akadeum Life Sciences
Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.
Conclusion:
The global cell separation market is witnessing strong growth driven by increasing demand for cell-based research, diagnostics, and therapeutic applications. Factors such as the rising incidence of chronic and infectious diseases, expanding biotechnology investments, and growing adoption of cell-based therapies are fueling market expansion. While high equipment costs and stringent regulatory requirements pose challenges, continuous technological advancements and automation are enhancing efficiency and precision. Established players dominate through extensive portfolios and global presence, while emerging companies focus on innovative and customizable solutions. With rising research activity and expanding biopharma infrastructure, the market outlook remains highly positive for the coming years.
